SESN2 Could Be a Potential Marker for Diagnosis and Prognosis in Glioma

(1) Background: Glioma is among the most common brain tumors, and is difficult to eradicate with current therapeutic strategies due to its highly invasive and aggressive characteristics. Sestrin2 (SESN2) is an autophagy inducer. The effect of SESN2 on glioma is controversial and unclear. (2) Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lingdan, Liu, Zelin, Wang, Huihui, Lu, Jiyuan, Xu, Jia, Meng, Yucheng, Huang, Ke, Liu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048065/
https://www.ncbi.nlm.nih.gov/pubmed/36980973
http://dx.doi.org/10.3390/genes14030701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048065/
https://www.ncbi.nlm.nih.gov/pubmed/36980973
http://dx.doi.org/10.3390/genes14030701

Ejemplares similares